BRUKER CORPORATION Proceeds from Maturities, Prepayments and Calls of Short-term Investments
BRUKER CORPORATION (BRKR) reported Proceeds from Maturities, Prepayments and Calls of Short-term Investments of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-03.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments · last filed 2025-03-03
- BRUKER CORPORATION proceeds from maturities, prepayments and calls of short-term investments for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- BRUKER CORPORATION proceeds from maturities, prepayments and calls of short-term investments for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- BRUKER CORPORATION proceeds from maturities, prepayments and calls of short-term investments for the quarter ending 2021-12-31 was $97.50M, a 95.00% increase year-over-year.
- BRUKER CORPORATION proceeds from maturities, prepayments and calls of short-term investments for the quarter ending 2021-09-30 was $700.00K, a 98.60% decline year-over-year.
- BRUKER CORPORATION proceeds from maturities, prepayments and calls of short-term investments for fiscal 2024 was $0.00.
- BRUKER CORPORATION proceeds from maturities, prepayments and calls of short-term investments for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- BRUKER CORPORATION proceeds from maturities, prepayments and calls of short-term investments for fiscal 2022 was $100.00M, a 1.83% increase from fiscal 2021.
- BRUKER CORPORATION proceeds from maturities, prepayments and calls of short-term investments for fiscal 2021 was $98.20M, a 7.45% decline from fiscal 2020.
| Period end | Proceeds from Maturities, Prepayments and Calls of Short-term Investments 3 month | Proceeds from Maturities, Prepayments and Calls of Short-term Investments 6 month | Proceeds from Maturities, Prepayments and Calls of Short-term Investments 9 month | Proceeds from Maturities, Prepayments and Calls of Short-term Investments 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-03 | |||
| 2023-12-31 | $0.00 10-K · filed 2025-03-03 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $0.00 derived: sum of 2 quarters · filed 2025-03-03 | $100.00M 10-K · filed 2025-03-03 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $100.00M 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | $100.00M 10-Q · filed 2023-08-09 | |||
| 2021-12-31 | $97.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $98.20M derived: sum of 2 quarters · filed 2024-02-29 | $98.20M 10-K · filed 2024-02-29 | |
| 2021-09-30 | $700.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $700.00K 10-Q · filed 2022-11-04 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-05 | |||
| 2020-12-31 | $50.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $100.00M derived: sum of 2 quarters · filed 2023-03-01 | $106.10M 10-K · filed 2023-03-01 | |
| 2020-09-30 | $50.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $56.10M 10-Q · filed 2021-11-05 | ||
| 2020-06-30 | $6.10M 10-Q · filed 2021-08-05 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $0.00 derived: sum of 2 quarters · filed 2021-03-01 | $0.00 derived: sum of 3 quarters · filed 2021-03-01 | $117.00M 10-K · filed 2021-03-01 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $0.00 derived: sum of 2 quarters · filed 2019-11-04 | $117.00M 10-Q · filed 2019-11-04 | $169.80M derived: sum of 4 quarters · filed 2020-03-27 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $117.00M 10-Q · filed 2019-08-09 | $169.80M derived: sum of 3 quarters · filed 2020-03-27 | $234.40M derived: sum of 4 quarters · filed 2020-03-27 |
| 2018-03-31 | $117.00M 10-Q · filed 2019-05-08 | $169.80M derived: sum of 2 quarters · filed 2020-03-27 | $234.40M derived: sum of 3 quarters · filed 2020-03-27 | $245.10M derived: sum of 4 quarters · filed 2020-03-27 |
| 2017-12-31 | $52.80M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $117.40M derived: sum of 2 quarters · filed 2020-03-27 | $128.10M derived: sum of 3 quarters · filed 2020-03-27 | $186.80M 10-K · filed 2020-03-27 |
| 2017-09-30 | $64.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $75.30M derived: sum of 2 quarters · filed 2018-11-09 | $134.00M 10-Q · filed 2018-11-09 | |
| 2017-06-30 | $10.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $69.40M 10-Q · filed 2018-08-09 | ||
| 2017-03-31 | $58.70M 10-Q · filed 2018-05-10 | |||
| 2016-12-31 | $165.00M 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |